Evidence map›Paper›PMID 32499748›Full record

ArticleFrontiers in neurology2020

Evidence of a Recessively Inherited CCN3 Mutation as a Rare Cause of Early-Onset Parkinsonism.

Steven R Bentley, Suliman Khan, Marco Öchsner, Susitha Premarathne, Zain Aslam, Javed Y Fowdar, Jamila Iqbal, Muhammad Naeem, Christopher A Love, Stephen A Wood and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Steven R BentleyGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Suliman KhanGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Marco ÖchsnerGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Susitha PremarathneGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Zain AslamDepartment of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Javed Y FowdarGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Jamila IqbalGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Muhammad NaeemDepartment of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Christopher A LoveGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Stephen A WoodGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
George D MellickGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Alex M SykesGriffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia.
Griffith University · AUQuaid-i-Azam University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of consanguineous families has provided novel insights into genetic causes of monogenic parkinsonism. Here, we present a family from the rural Khyber Pakhtunkhwa province, Pakistan, where three siblings were diagnosed with early-onset parkinsonism. Homozygosity mapping of two affected siblings and three unaffected family members identified two candidate autozygous loci segregating with disease, 8q24.12-8q24.13 and 9q31.2-q33.1. Whole-exome sequence analysis identified a single rare homozygous missense sequence variant within this region,

Indexed as

CCN3early-onsetextracellular matrixgeneticNOVparkinson

Identifiers

PMID32499748
PMCPMC7242651
OpenAlexW3025122164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.